• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MOLECULAR, INC. ALINITY M HCV AMP KIT; ASSAY, HYBRIDIZATION AND/OR NUCLEIC ACID AMPLIFICATION FOR DETECTION OF HEPATITI

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MOLECULAR, INC. ALINITY M HCV AMP KIT; ASSAY, HYBRIDIZATION AND/OR NUCLEIC ACID AMPLIFICATION FOR DETECTION OF HEPATITI Back to Search Results
Catalog Number 08N50-095
Device Problems False Positive Result (1227); Unable to Obtain Readings (1516)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/05/2023
Event Type  malfunction  
Event Description
Through complaint investigation, abbott has identified an increase in potential for reactive negative controls (nc) as well as separate instances of false positive results in patient samples when using specific lots of alinity m hcv amp kit.It was discovered that these specific lots of alinity m hcv amp kit have lower than the expected range of hcv reference dye fluorescence.A product deficiency was identified for these specific lots of alinity m hcv assay.The potential hazards associated with this issue are incorrect results (false positive) and delay of results (reactive nc requiring a re-test).Field action fa-am-oct2023-293, was taken to address this issue.It was deemed reportable per 21cfr806 and therefore will be reported under 21cfr803.
 
Manufacturer Narrative
Based on the customer data review of the complaint investigation, it was identified that the amplification curves for a majority of samples were not sigmoidal and have a data reduction issue for the fam target.It was discovered that specific lots of alinity m hcv amp kit have lower than the expected range of hcv reference dye fluorescence and resulted in an artificial non-sigmoidal amplification curve and false positive results.Therefore, the complaint was dispositioned as confirmed for product deficiency.The following material lot information is included in this confirmed product deficiency.List number: 08n50-090 lot number: 383203, date of manufacture: 03/27/2023, expiration date: 12/30/2024 (b)(4) lot number: 385720, date of manufacture: 05/11/2023, expiration date: 02/26/2025 ,(b)(4) lot number: 381581, date of manufacture: 12/20/2022, expiration date:10/06/2024, (b)(4)lot number: 382447, date of manufacture: 02/07/2023, expiration date: 11/11/2024, (b)(4) list number: 08n50-095 lot number: 381582, date of manufacture: 01/04/2023, expiration date:10/06/2024, (b)(4) lot number: 382448, date of manufacture: 03/01/2023, expiration date:11/11/2024, (b)(4)on (b)(6) 2023, a decision was made to issue a customer letter (urgent field safety notice / field correction recall) to notify customers of the reported issue.Field action fa-am-oct2023-293, was issued on (b)(6) 2023.It was deemed reportable per 21cfr806 and therefore will be reported under 21cfr803.Initial notification to the fda per 21cfr806 was completed on (b)(6) 2023.
 
Manufacturer Narrative
Updated field action fa-am-oct2023-293v2 was issued on july 23, 2024, to notify customers that material impacted by the issue was not segregated as required and an additional lot of impacted alinity m hcv amp kit list number 08n50-095 was distributed.Initial notification to the fda of this updated field correction recall was completed on july 24, 2024.The following material lot information is included in this confirmed product deficiency: list number: 08n50-095.Lot number: 383204, date of manufacture: 2024-01-22, expiration date: 2024-12-30.Udi: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY M HCV AMP KIT
Type of Device
ASSAY, HYBRIDIZATION AND/OR NUCLEIC ACID AMPLIFICATION FOR DETECTION OF HEPATITI
Manufacturer (Section D)
ABBOTT MOLECULAR, INC.
1300 e. touhy ave.
des plaines 60018 3315
Manufacturer (Section G)
ABBOTT MOLECULAR, INC.
1300 e. touhy ave.
des plaines IL 60018 3315
Manufacturer Contact
albert chianello
1300 e. touhy ave.
des plaines, IL 60018-3315
2242064064
MDR Report Key18089017
MDR Text Key328417556
Report Number3005248192-2023-00279
Device Sequence Number1
Product Code MZP
UDI-Device Identifier00884999047761
UDI-Public(01)00884999047761(10)381582(17)241006(240)08N50-095
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P190025
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Non-Healthcare Professional
Remedial Action Recall
Type of Report Initial,Followup
Report Date 07/30/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Expiration Date10/06/2024
Device Catalogue Number08N50-095
Device Lot Number381582
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 10/12/2023
Initial Date FDA Received11/07/2023
Supplement Dates Manufacturer Received07/18/2024
Supplement Dates FDA Received07/30/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/04/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction Number3005248192-10/30/23-002R
Patient Sequence Number1
-
-